Neoadjuvant Chemoradiotherapy: Clinical Trials

4 trials for Neoadjuvant Chemoradiotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 recruiting. 4 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable4Unknown 2, Completed 1, Recruiting 1

Follow Neoadjuvant Chemoradiotherapy: new trials by email Literature Review of Neoadjuvant Chemoradiotherapy trials Research Report on Neoadjuvant Chemoradiotherapy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients
Oral Immunonutrition - Pancreatic Cancer, Neoadjuvant Chemoradiotherapy
Not applicableUnknownSun Yat-sen University982024-08-262024-12-17
THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy
RT Dose escalation in LARC patients with an Early Regression Index > 13.1 at second week on nCRT - Neoadjuvant Chemoradiotherapy, Locally Advanced Rectal Cancer
Not applicableRecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1792021-03-172026-07-10
Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma
Higher dose (50.4Gy/28F) of neoadjuvant chemoradiation, Lower dose (41.4Gy/23F) of neoadjuvant chemoradiation - Esophageal Carcinoma, Neoadjuvant Chemoradiotherapy
Not applicableCompletedZhejiang Cancer Hospital1472018-02-222024-11-18
Statistical Analysis Plan for the SANO-trial: Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Active Surveillance for Oesophageal Cancer
Active surveillance - Esophageal Cancer, Active Surveillance
Not applicableUnknownErasmus Medical Center7762017-11-012024-09-19

Narrower conditions

Esophageal Neoplasms (2)  ·  Pancreatic Neoplasms (1)

Broader conditions

Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Esophageal Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Head and Neck Neoplasms (2)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Pancreatic Diseases (1)

Interventions

Immunonutrition Diet (1)  ·  Neoadjuvant Therapy (1)  ·  Watchful Waiting (1)

Sponsors

Erasmus Medical Center (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Sun Yat-sen University (1)  ·  Zhejiang Cancer Hospital (1)

Countries

China (2)  ·  Italy (1)  ·  Netherlands (1)

Top investigators

Giuditta Chiloiro, MD PhD (1)  ·  Weimin Mao, M.D. (1)  ·  Weiwei Xiao (1)

Results publications

PMID 35033008, PMID 42551632